Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test

Cell Biochemistry and Biophysics

Volumn 65, Issue 3, 2013, Pages 473-483

  Sartini, Davide ^a   Muzzonigro, Giovanni ^a   Milanese, Giulio ^a   Pozzi, Valentina ^a   Vici, Alexia ^a   Morganti, Stefano ^a   Rossi, Valentina ^a   Mazzucchelli, Roberta ^a   Montironi, Rodolfo ^a   Emanuelli, Monica ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Carcinoma; Diagnostic marker; Gene expression; NNMT

Indexed keywords

EID: 84875215587     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-012-9451-1     Document Type: Article

References (42)

1. Cheng, L., Zhang, S., MacLennan, G. T., Williamson, S. R., Lopez-Beltran, A., & Montironi, R. (2011). Bladder cancer: Translating molecular genetic insights into clinical practice. Human Pathology, 42, 455-481.
2. Morgan, T. M., & Clark, P. E. (2010). Bladder cancer. Current Opinion in Oncology, 22, 242-249.
3. van Tilborg, A. A., Bangma, C. H., & Zwarthoff, E. C. (2009). Bladder cancer biomarkers and their role in surveillance and screening. International Journal of Urology, 16, 23-30.
4. Aksoy, S., Szumlanski, C. L., & Weinshilboum, R. M. (1994). Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. Journal of Biological Chemistry, 269, 14835-14840.
5. Peng, Y., Sartini, D., Pozzi, V., Wilk, D., Emanuelli, M., & Yee, V. C. (2011). Structural basis of substrate recognition in human nicotinamide N-methyltransferase. Biochemistry, 50, 7800-7808.
6. Sartini, D., Muzzonigro, G., Milanese, G., Pierella, F., Rossi, V., & Emanuelli, M. (2006). Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal clear cell carcinoma. Journal of Urology, 176, 2248-2254.
7. Sartini, D., Santarelli, A., Rossi, V., Goteri, G., Rubini, C., Ciavarella, D., et al. (2007). Nicotinamide N-methyltransferase upregulation inversely correlates with lymph node metastasis in oral squamous cell carcinoma. Molecular Medicine, 13, 415-421.
8. Emanuelli, M., Santarelli, A., Sartini, D., Ciavarella, D., Rossi, V., Pozzi, V., et al. (2010). Nicotinamide N-Methyltransferase upregulation correlates with tumour differentiation in oral squamous cell carcinoma. Histology and Histopathology, 25, 15-20.
9. Pozzi, V., Mazzotta, M., Lo Muzio, L., Sartini, D., Santarelli, A., Renzi, E., et al. (2011). Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. International Journal of Immunopathology and Pharmacology, 24, 69-77.
10. Edge, S. B., Byrd, D. R., Compton, C. C., Fritz, A. G., Greene, F. L., & Trotti, A. (2010). Urinary bladder, in AJCC cancer staging handbook: From the AJCC cancer staging manual (7th ed., pp. 569-578). New York: Springer-Verlag.
11. Eble, J. N., Sauter, G., Epstein, J. I., & Sesterhenn, I. A. (2004). Tumours of the urinary system, in World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs (pp. 89-158). Lyon: IARC Press.
12. Balducci, E., Orsomando, G., Polzonetti, V., Vita, A., Emanuelli, M., Raffaelli, N., et al. (1995). NMN adenylyltransferase from bull testis: Purification and properties. Biochemical Journal, 310, 395-400.
13. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72, 248-254.
14. Shirodkar, S. P., & Lokeshwar, V. B. (2009). Potential new urinary markers in the early detection of bladder cancer. Current Opinion in Urology, 19, 488-493.
15. Szakács, G., Annereau, J. P., Lababidi, S., Shankavaram, U., Arciello, A., Bussey, K. J., et al. (2004). Predicting drug sensitivity and resistance: Profiling ABC transporter genes in cancer cells. Cancer Cell, 6, 129-137.
16. Okamoto, H., Ishikawa, A., Yoshitake, Y., Kodama, N., Nishimuta, M., Fukuwatari, T., et al. (2003). Diurnal variations in human urinary excretion of nicotinamide catabolites: Effects of stress on the metabolism of nicotinamide. American Journal of Clinical Nutrition, 77, 406-410.
17. Markert, J. M., Fuller, C. M., Gillespie, G. Y., Bubien, J. K., McLean, L. A., Hong, R. L., et al. (2001). Differential gene expression profiling in human brain tumors. Physiological Genomics, 5, 21-33.
18. Jang, J. S., Cho, H. Y., Lee, Y. J., Ha, W. S., & Kim, H. W. (2004). The differential proteome profile of stomach cancer: Identification of the biomarker candidates. Oncology Research, 14, 491-499.
19. Xu, J., Moatamed, F., Caldwell, J. S., Walker, J. R., Kraiem, Z., Taki, K., et al. (2003). Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells. Journal of Clinical Endocrinology and Metabolism, 88, 4990-4996.
20. Roessler, M., Rollinger, W., Palme, S., Hagmann, M. L., Berndt, P., Engel, A. M., et al. (2005). Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clinical Cancer Research, 11, 6550-6557.
21. Kim, J., Hong, S. J., Lim, E. K., Yu, Y. S., Kim, S. W., Roh, J. H., et al. (2009). Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis. Journal of Experimental and Clinical Cancer Research, 28, 20.
22. Tomida, M., Mikami, I., Takeuchi, S., Nishimura, H., & Akiyama, H. (2009). Serum levels of nicotinamide N-methyltransferase in patients with lung cancer. Journal of Cancer Research and Clinical Oncology, 135, 1223-1229.
23. Rogers, C. D., Fukushima, N., Sato, N., Shi, C., Prasad, N., Hustinx, S. R., et al. (2006). Differentiating pancreatic lesions by microarray and QPCR analysis of pancreatic juice RNAs. Cancer Biology & Therapy, 5, 1383-1389.
24. Debigaré, R., Maltais, F., Côté, C. H., Michaud, A., Caron, M. A., Mofarrahi, M., et al. (2008). Profiling of mRNA expression in quadriceps of patients with COPD and muscle wasting. COPD, 5, 75-84.
25. Mateuszuk, Ł., Khomich, T. I., Słomińska, E., Gajda, M., Wójcik, L., Łomnicka, M., et al. (2009). Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis. Pharmacological Reports, 61, 76-85.
26. Williams, A. C., & Ramsden, D. B. (2005). Autotoxicity, methylation and a road to the prevention of Parkinson's disease. Journal of Clinical Neuroscience, 12, 6-11.
27. Wu, Y., Siadaty, M. S., Berens, M. E., Hampton, G. M., & Theodorescu, D. (2008). Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration. Oncogene, 27, 6679-6689.
28. Parsons, R. B., Aravindan, S., Kadampeswaran, A., Evans, E. A., Sandhu, K. K., Levy, E. R., et al. (2011). The expression of nicotinamide N-methyltransferase increases ATP synthesis and protects SH-SY5Y neuroblastoma cells against the toxicity of complex I inhibitors. Biochemical Journal, 436, 145-155.
29. Tang, S. W., Yang, T. C., Lin, W. C., Chang, W. H., Wang, C. C., Lai, M. K., et al. (2011). Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clear cell renal cell carcinoma cells. Carcinogenesis, 32, 138-145.
30. Kim, H. C., Mofarrahi, M., Vassilakopoulos, T., Maltais, F., Sigala, I., Debigare, R., et al. (2010). Expression and functional significance of nicotinamide N-methyltransferase in skeletal muscles of patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 181, 797-805.
31. Williams, A. C., & Ramsden, D. B. (2005). Nicotinamide homeostasis: A xenobiotic pathway that is key to development and degenerative diseases. Medical Hypotheses, 65, 353-362.
32. Zhang, J. (2003). Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked? BioEssays, 25, 808-814.
33. Kassem, H Sh, Sangar, V., Cowan, R., Clarke, N., & Margison, G. P. (2002). A potential role of heat shock proteins and nicotinamide N-methyl transferase in predicting response to radiation in bladder cancer. International Journal of Cancer, 101, 454-460.
34. D'Andrea, F. P., Safwat, A., Kassem, M., Gautier, L., Overgaard, J., & Horsman, M. R. (2011). Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance. Radiotherapy and Oncology, 99, 373-378.
35. Audrito, V., Vaisitti, T., Rossi, D., Gottardi, D., D'Arena, G., Laurenti, L., et al. (2011). Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network. Cancer Research, 71, 4473-4483.
36. Chlopicki, S., Swies, J., Mogielnicki, A., Buczko, W., Bartus, M., Lomnicka, M., et al. (2007). 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway. British Journal of Pharmacology, 152, 230-239.
37. Bartuś, M., Łomnicka, M., Kostogrys, R. B., Kaźmierczak, P., Watała, C., Słominska, E. M., et al. (2008). 1-Methylnicotinamide (MNA) prevents endothelial dysfunction in hypertriglyceridemic and diabetic rats. Pharmacological Reports, 60, 127-138.
38. Brzozowski, T., Konturek, P. C., Chlopicki, S., Sliwowski, Z., Pawlik, M., Ptak-Belowska, A., et al. (2008). Therapeutic potential of 1-methylnicotinamide against acute gastric lesions induced by stress: Role of endogenous prostacyclin and sensory nerves. Journal of Pharmacology and Experimental Therapeutics, 326, 105-116.
39. Sternak, M., Khomich, T. I., Jakubowski, A., Szafarz, M., Szczepański, W., Białas, M., et al. (2010). Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse. Pharmacological Reports, 62, 483-493.
40. Xu, J., Capezzone, M., Xu, X., & Hershman, J. M. (2005). Activation of nicotinamide N-methyltransferase gene promoter by hepatocyte nuclear factor-1beta in human papillary thyroid cancer cells. Molecular Endocrinology, 19, 527-539.
41. Xu, J., & Hershman, J. M. (2006). Histone deacetylase inhibitor depsipeptide represses nicotinamide N-methyltransferase and hepatocyte nuclear factor-1beta gene expression in human papillary thyroid cancer cells. Thyroid, 16, 151-160.
42. Tomida, M., Ohtake, H., Yokota, T., Kobayashi, Y., & Kurosumi, M. (2007). Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells. Journal of Cancer Research and Clinical Oncology, 134, 551-559.